BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Gliclazide

An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

300+ PubMed studies analyzed · 47 RCTs · Evidence Score: 54.1

Research Domains

Gliclazide has been studied across 13 research domains including 🔥 Metabolic, 🧬 Hormones, 🔬 Inflammation, 🧘 Stress & Anxiety, 🫁 Liver & Detox. The primary research focus is 🔥 Metabolic with 79% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gliclazide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Kynurenic
2 shared targets
Diiodotyrosine
2 shared targets
Ciclopirox
2 shared targets
Epinephrine
2 shared targets
Masoprocol
2 shared targets
celastrol
2 shared targets
piceatannol
2 shared targets
Luteolin
2 shared targets
Disulfiram
2 shared targets
Hexachlorophene
2 shared targets
Loading evidence profile...

This evidence profile for Gliclazide is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.